Cohort plc (LON:CHRT - Get Free Report)'s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,273.72 ($17.38) and traded as high as GBX 1,568 ($21.40). Cohort shares last traded at GBX 1,568 ($21.40), with a volume of 98,251 shares traded.
Wall Street Analyst Weigh In
Separately, Shore Capital reissued a "buy" rating on shares of Cohort in a report on Thursday, May 29th.
Read Our Latest Report on Cohort
Cohort Stock Performance
The company has a debt-to-equity ratio of 37.28, a quick ratio of 0.93 and a current ratio of 1.55. The firm's 50 day simple moving average is GBX 1,493.41 and its 200 day simple moving average is GBX 1,273.72. The firm has a market capitalization of £704.46 million, a price-to-earnings ratio of 40.99 and a beta of 0.56.
Insiders Place Their Bets
In other news, insider Simon Walther sold 350 shares of the business's stock in a transaction dated Wednesday, April 23rd. The stock was sold at an average price of GBX 1,275 ($17.40), for a total value of £4,462.50 ($6,090.49). Also, insider Andrew Stephen Thomis sold 5,358 shares of the business's stock in a transaction dated Wednesday, April 9th. The shares were sold at an average price of GBX 1,120 ($15.29), for a total value of £60,009.60 ($81,902.01). Insiders own 39.22% of the company's stock.
Cohort Company Profile
(
Get Free Report)
Cohort plc is the parent company of seven innovative, agile and responsive businesses based in the UK, Australia, Germany and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.
The Group is split into two segments:
Communications and Intelligence
- EID designs and manufactures advanced communications systems for naval and military customers.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cohort, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cohort wasn't on the list.
While Cohort currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.